@article{orfanosObservationalStudyUse2020,
 abstract = {Tweetable abstract @ERSpublications click to tweet#COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a},
 author = {Orfanos, Sarah and Husseini, Ibrahim El and Nahass, Thomas and Radbel, Jared and Hussain, Sabiha},
 chapter = {Original research letters},
 copyright = {Copyright Â© ERS 2020. http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.},
 doi = {10.1183/23120541.00455-2020},
 file = {/Users/tomnahass/Zotero/storage/UN75XNCV/Orfanos et al. - 2020 - Observational study of the use of recombinant tiss.pdf;/Users/tomnahass/Zotero/storage/B69TUEH4/00455-2020.html},
 issn = {2312-0541},
 journal = {ERJ Open Research},
 langid = {english},
 month = {October},
 number = {4},
 publisher = {European Respiratory Society},
 title = {Observational Study of the Use of Recombinant Tissue-Type Plasminogen Activator in COVID-19 Shows a Decrease in Physiological Dead Space},
 volume = {6},
 year = {2020}
}

